0 By jay In Press ReleasesPosted April 16, 2021Axial Therapeutics to Present at Virtual Jefferies Microbiome-based Therapeutics SummitApril 15, 2021 READ MORE
1 By jay In Press ReleasesPosted March 8, 2021Axial Therapeutics Promotes A. Stewart Campbell to Chief Executive OfficerMarch 8, 2021 READ MORE
1 By jay In Press ReleasesPosted January 6, 2021Axial Therapeutics to Present at the Inaugural Virtual H.C. Wainwright BioConnect ConferenceJanuary 6, 2021 READ MORE
0 By jay In Press ReleasesPosted January 4, 2021Axial Therapeutics to Present at the ACCESS CHINA Forum @JPM WEEK 2021December 30, 2020 READ MORE
0 By jay In Press ReleasesPosted December 8, 2020Axial Therapeutics to Present at the 2020 RBC Capital Markets Healthcare Private Company ConferenceDec. 8, 2020 READ MORE
29 By jay In Press ReleasesPosted December 3, 2020Results from Axial Therapeutics Phase1b/2a Study of AB-2004 in Adolescents with Autism Spectrum Disorder Met Primary Endpoint and Reduced Irritability and Other SymptomsDec. 3, 2020 READ MORE
0 By jay In Press ReleasesPosted November 25, 2020Axial Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceNovember 25, 2020 READ MORE
0 By jay In Press ReleasesPosted November 16, 2020Axial Therapeutics to Participate in a Fireside Chat Hosted by LifeSci CapitalNovember 16, 2020 READ MORE
0 By jay In Press ReleasesPosted September 22, 2020Axial Biotherapeutics Appoints Federico Bolognani, M.D., Ph.D., Vice President and Head of Clinical ScienceSeptember 22, 2020 READ MORE
0 By jay In Press ReleasesPosted September 15, 2020Axial Biotherapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceSeptember, 15, 2020 READ MORE
